同: PTLD
関: Post-transplantation lymphoprolifereative disorder

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2012/10/30 10:04:15」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 移植後リンパ球増殖性疾患の疫学、臨床症状、および診断 epidemiology clinical manifestations and diagnosis of post transplant lymphoproliferative disorders
2. 移植後のリンパ球増殖性疾患の治療および予防 treatment and prevention of post transplant lymphoproliferative disorders
3. 小腸および多臓器移植の概要 overview of intestinal and multivisceral transplantation
4. エプスタインバーウイルス（EBウイルス）感染の臨床的特徴および治療 clinical manifestations and treatment of epstein barr virus infection
5. 造血細胞移植後の悪性腫瘍 malignancy after hematopoietic cell transplantation

English Journal

Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab.

van der Velden WJ, Mori T, Stevens WB, de Haan AF, Stelma FF, Blijlevens NM, Donnelly JP.Source1] Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands [2] Nijmegen Institute for Infection, Inflammation and Immunity (N4i), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Bone marrow transplantation.Bone Marrow Transplant.2013 Jun 10. doi: 10.1038/bmt.2013.84. [Epub ahead of print]
The mortality associated with post-transplant lymphoproliferative disorder (PTLD) induced by EBV infection can be reduced by monitoring EBV by polymerase-chain-reaction and rituximab given pre-emptively. We performed a retrospective analysis of the risk factors for the occurrence of EBV infection/di
PMID 23749107

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies.

Chen BJ, Chapuy B, Ouyang J, Sun HH, Roemer MG, Xu ML, Yu H, Fletcher CD, Freeman GJ, Shipp MA, Rodig SJ.SourceAuthors' Affiliations: Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Department of Pathology, UMass Memorial Medical Center, University of Massachusetts Medical School, Worcester, Massachusetts; and Yale School of Medicine, New Haven, Connecticut.
Clinical cancer research : an official journal of the American Association for Cancer Research.Clin Cancer Res.2013 Jun 10. [Epub ahead of print]
PURPOSE: Programmed cell death ligand 1 (PD-L1) is an immunomodulatory molecule expressed by antigen-presenting cells and select tumors that engages receptors on T cells to inhibit T-cell immunity. Immunotherapies targeting the PD-1/PD-L1 pathway have shown durable antitumor effects in a subset of p
PMID 23674495

Successful treatment of central nervous system PTLD with rituximab and cranial radiotherapy.

Said-Conti V, Amrolia PJ, Gaze MN, Stoneham S, Sebire N, Shroff R, Marks SD.SourceDepartment of Paediatric Nephrology, Great Ormond Street Hospital NHS Trust, London, UK, valerie.said@gov.mt.
Pediatric nephrology (Berlin, Germany).Pediatr Nephrol.2013 Jun 7. [Epub ahead of print]
BACKGROUND: Primary central nervous system (PCNS) post-transplant lymphoproliferative disorder (PTLD) is a rare complication of solid organ transplantation and is typically an Epstein-Barr virus (EBV)-induced B-cell CD20+ lymphoma. The modalities of treatment include reduction in immunosuppression,
PMID 23743853

Japanese Journal

免疫抑制剤減量のみで寛解に至った中枢神経原発移植後リンパ増殖性疾患

皆内康一郎,小泉和輝,近藤真,滝上昌良,原田浩,藤田裕実,向井正也
臨床血液 52(5), 272-277, 2011-05-30
NAID 10029424878

Immunotherapy for EBV-associated malignancies

MERLO Anna,TURRINI Riccardo,DOLCETTI Riccardo,ZANOVELLO Paola,ROSATO Antonio
International journal of hematology 93(3), 281-293, 2011-03-01
NAID 10029533624

Related Pictures

of the spectrum of EBV- associated PTLD 09262 - Infectious mononucleosis-like PTLD postrasplante (TLPT o PTLD after Transplant: Trying to Avoid PTLD Unfortunately we are unable to provide 後リンパ増殖性疾患（PTLD Juxtapositions for PTLD this polymorphic ptld note the intact